You are here: Industry Insights > Clinical Trials

News List

Weekly Pharma News Review | PharmaSources.com （April.18th - 22ed） PharmaSources.com
April 27, 2022
The pharma news review of this week totally covers 22 pieces of news in 3 sections, including drug review, R&D, and business.
With the BGB-16673 Clinical Trials of BeiGene Launched, PROTAC Leads a Brand New Trend of Global Competition PharmaSources/Wanghong
March 21, 2022
On February 28, BGB-16673, a BTK-targeted PROTAC drug of BeiGene, was launched for clinical trials for the first time in China.
Innovent's PD-1 suffered setbacks in the listing of overseas market, a paradigm for Chinese innovative drug in the global market PharmaSources/Caicai
February 22, 2022
Recently, FDA held an ODAC (Oncologic Drugs Advisory Committee) meeting around the key event in the listing application of Sintilimab, Innovent's PD-1 monoclonal antibody, in the United States.
Decentralized Clinical Trials— The Tomorrow of Clinical Research Lin Zhang
April 07, 2021
The Coronavirus disease 2019 (COVID-19) pandemic has led to many changes in the way different processes are handled. In particular, it is profoundly disrupting clinical research.
Getting Clinical Trials Back on Track Sarah Harding
February 04, 2021
I think it is fair to say that R&D is the lifeblood of the pharma industry, and no drug discovery program can be completed without its clinical trials.
CDE Issues Document to Promote the Launch Progress of COVID-19 Vaccines, Global Overiew of 7 Vaccine Clinical Trials PharmaSources/Xiaoyaowan
August 21, 2020
CDE Issues Document to Promote the Launch Progress of COVID-19 Vaccines, Global Overiew of 7 Clinical Trials.
The Impact of Coronavirus (COVID-19) on Global Pharmaceutical Industry Lin Zhang
April 13, 2020
Alongside the human impact of COVID-19 pandemic outbreak and the economic downfall caused by its spread, COVID-19 is? having a growing impact on the global?pharmaceutical industry.
China Disclosed Research Data of PiCoVacc, an Inactivated Virus Vaccine against COVID-19 CPhI.CN
April 21, 2020
On April 19, the Chinese Academy of Medical Sciences uploaded an article entitled "Rapid development of an inactivated vaccine for SARS-CoV-2" in BioRxiv.
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards PharmaSources
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
First-in-Human Clinical Data Shows SonoTran? is Safe and Well-Tolerated PharmaSources
January 23, 2023
OxSonics Therapeutics, announces that first-in-human clinical data demonstrated that SonoTran? is safe and well-tolerated, with consistent Particle activation observed and mapped using OxSonics’ proprietary “see-as-you-treat” technology.